Publication | Closed Access

Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity

NanoparticlesNanomedicineCell-based Drug DeliveryBiocompatible Gemcitabine-based NanomedicineEngineeringTherapeutic NanomaterialsEfficient Antitumor ActivityPharmaceutical NanotechnologyFlow Focusing®Tumor TargetingNano-drug DeliveryBiomedical EngineeringCancer Engineering